CytoDyn Inc., a clinical-stage biotechnology company, develops treatments for multiple therapeutic indications. The company develops leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19. Its leronlimab completed phase 2...
18 insider purchases on record · latest filing 2020-11-03.
Insiders have also filed 40 sale transactions at CYDY.